- Home
- TACO vs PACB Comparison
TACO vs PACB Comparison
Compare TACO & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACO
- PACB
- Stock Information
- Founded
- TACO 2024
- PACB 2000
- Country
- TACO United States
- PACB United States
- Employees
- TACO N/A
- PACB N/A
- Industry
- TACO Blank Checks
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- TACO Finance
- PACB Industrials
- Exchange
- TACO Nasdaq
- PACB Nasdaq
- Market Cap
- TACO 389.8M
- PACB 364.2M
- IPO Year
- TACO 2025
- PACB 2010
- Fundamental
- Price
- TACO $10.39
- PACB $1.29
- Analyst Decision
- TACO
- PACB Buy
- Analyst Count
- TACO 0
- PACB 9
- Target Price
- TACO N/A
- PACB $2.06
- AVG Volume (30 Days)
- TACO 313.6K
- PACB 10.1M
- Earning Date
- TACO 01-01-0001
- PACB 08-06-2025
- Dividend Yield
- TACO N/A
- PACB N/A
- EPS Growth
- TACO N/A
- PACB N/A
- EPS
- TACO N/A
- PACB N/A
- Revenue
- TACO N/A
- PACB $152,357,000.00
- Revenue This Year
- TACO N/A
- PACB $3.33
- Revenue Next Year
- TACO N/A
- PACB $18.52
- P/E Ratio
- TACO N/A
- PACB N/A
- Revenue Growth
- TACO N/A
- PACB N/A
- 52 Week Low
- TACO $10.10
- PACB $0.85
- 52 Week High
- TACO $11.26
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- TACO N/A
- PACB 57.95
- Support Level
- TACO N/A
- PACB $1.14
- Resistance Level
- TACO N/A
- PACB $1.35
- Average True Range (ATR)
- TACO 0.00
- PACB 0.10
- MACD
- TACO 0.00
- PACB 0.00
- Stochastic Oscillator
- TACO 0.00
- PACB 60.71
About TACO Berto Acquisition Corp. Ordinary Shares
Berto Acquisition Corp is a blank check company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.